CLINICAL_TRIALS
trial_result
· 2014-05-01
Clinical Trial Update: Melatonin and the Metabolic Syndrome [Phase 2]
Summary
A Phase 2 trial evaluating melatonin for metabolic syndrome has completed, and the results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Metabolic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-05-01